The effects of antenatal magnesium sulfate on feeding intolerance and necrotizing enterocolitis in preterm infants

Ipek Guney Varal1, Gaffari Tunc2, Hilal Kucuk3

  • 1University of Health Sciences Bursa Yuksek Ihtisas Teaching Hospital, Department of Pediatrics, Division of Neonatology, Bursa, Türkiye, Türkiye. ipekguneyvaral@gmail.com.

Ginekologia Polska
|July 4, 2025
PubMed

Insights

Antenatal magnesium sulfate may increase feeding intolerance in preterm infants, but does not affect necrotizing enterocolitis. This finding is crucial for neonatal care providers managing high-risk pregnancies.

Area of Science:

  • Neonatalogy
  • Perinatology
  • Pediatric Gastroenterology

Background:

  • Antenatal magnesium sulfate is used for its tocolytic and neuroprotective benefits in preterm births.
  • The impact on neonatal gastrointestinal outcomes requires further investigation.

Purpose of the Study:

  • To evaluate the association between antenatal magnesium sulfate administration and feeding intolerance in preterm infants.
  • To assess the effect on necrotizing enterocolitis and spontaneous intestinal perforation.

Main Methods:

  • Observational cohort study of preterm infants (< 30 weeks gestational age or < 1250 g).
  • Infants were divided into two groups: those who received antenatal magnesium sulfate and those who did not.
  • Logistic regression analysis was used to identify independent risk factors for feeding intolerance.

Main Results:

  • Infants receiving antenatal magnesium sulfate had a shorter time to full enteral feeding and less total parenteral nutrition.
  • Magnesium sulfate administration was identified as an independent risk factor for feeding intolerance (adjusted OR: 3.5).
  • No significant effect was observed on spontaneous intestinal perforation or necrotizing enterocolitis.

Conclusions:

  • Antenatal magnesium sulfate may increase the risk of feeding intolerance in preterm infants.
  • It does not appear to increase the risk of necrotizing enterocolitis or intestinal perforation.
  • Clinicians should consider the potential for feeding intolerance when administering antenatal magnesium sulfate.
Abstract